Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Acadia Pharmaceuticals Inc (NASDAQ: ACAD) was $22.29 for the day, up 1.23% from the previous closing price of $22.02. In other words, the price has increased by $1.23 from its previous closing price. On the day, 1.39 million shares were traded.
Ratios:
Our analysis of ACAD’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.47 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 25.13. For the most recent quarter (mrq), Quick Ratio is recorded 2.80 and its Current Ratio is at 2.88. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On February 11, 2025, Deutsche Bank started tracking the stock assigning a Hold rating and target price of $22.
Guggenheim Downgraded its Buy to Neutral on January 03, 2025, whereas the target price for the stock was revised from $23 to $20.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 16 ’25 when Kihara James sold 4,000 shares for $22.50 per share. The transaction valued at 90,000 led to the insider holds 20,395 shares of the business.
Schneyer Mark C. sold 2,000 shares of ACAD for $50,000 on May 16 ’25. The EVP, CHIEF FINANCIAL OFFICER now owns 62,130 shares after completing the transaction at $25.00 per share. On May 16 ’25, another insider, Schneyer Mark C., who serves as the Officer of the company, bought 2,000 shares for $17.60 each.
Valuation Measures:
As of this moment, Acadia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.23, and their Forward P/E ratio for the next fiscal year is 26.00. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.42. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.74 while its Price-to-Book (P/B) ratio in mrq is 4.87.
Stock Price History:
Over the past 52 weeks, ACAD has reached a high of $25.23, while it has fallen to a 52-week low of $13.40. The 50-Day Moving Average of the stock is 32.41%, while the 200-Day Moving Average is calculated to be 32.36%.
Shares Statistics:
A total of 167.12M shares are outstanding, with a floating share count of 166.06M. Insiders hold about 0.78% of the company’s shares, while institutions hold 103.62% stake in the company.
